thromboembolism

1. The correlation analysis of embolism area and basis diseases in patients with pulmonary thromboembolism
   129例住院肺血栓栓塞症患者栓塞面积与基础疾病相关性的分析
2. The Relationship of Venous Thromboembolism with Antiphospholipid Antibody and Anticoagulant Protein System in Systemic Lupus Erythematosus Patients
   抗磷脂抗体和抗凝蛋白系统与系统性红斑狼疮静脉血栓形成的关系
3. According to statistics, venous thromboembolism is a common disease in-patients and an important cause of death.
   据统计，静脉血栓栓塞是住院病人常见的病变和重要死亡原因。
4. AIM: To assess the efficacy and safety of fondaparinux versus low molecular weight heparin ( LMWH) for the prevention of pulmonary thromboembolism ( PTE) after surgery.
   目的：评估磺达肝素对术后发生肺血栓栓塞（PTE）的预防作用，并系统分析磺达肝素和一般低分子肝素（LMWH）疗效和安全性的差异。
5. To investigate the changes of anticoagulation system in patients with pulmonary thromboembolism ( PTE) and evaluate its diagnostic value.
   探讨肺血栓栓塞症（PTE）患者抗凝系统的变化及其对诊断的价值。
6. Fondaparinux sodium also prevented venous thromboembolism.
   磺达肝素钠也能够减少静脉血栓。
7. Objective To evaluate the curative effect of interventional comprehensive therapy for pulmonary thromboembolism ( PTE).
   目的评价介入综合治疗急性肺血栓栓塞症（PTE）的疗效。
8. The main complications were valve mechanical malfunction, peri-prosthetic leak, hemolysis, thromboembolism and infective endocarditis.
   发生并发症有机械瓣膜功能障碍、瓣周漏、溶血、栓塞、感染性心内膜炎发生。
9. Objective To improve recognition of PE ′ s ( pulmonary thromboembolism) pathogenesis, diagnosis and treatment.
   目的提高对肺栓塞发病机制及诊断治疗的认识。
10. Protective Effects of PDTC on Reperfusion Injury after Thrombolysis in Rats with Acute Pulmonary Thromboembolism
    PDTC对大鼠急性肺血栓栓塞症溶栓后再灌注损伤的保护性研究
11. The imaging manifestation comparison analysis between pulmonary artery sarcoma and pulmonary artery thromboembolism Local caliber of vein thrombus in 6 cases was evidently broadened.
    肺动脉肉瘤与肺动脉血栓栓塞影像学对比分析（4）6例静脉血栓局部的管径明显增宽。
12. The second study in the journal looked at36 published research papers dealing with medications used to prevent venous thromboembolism.
    杂志上的第二项研究分析了有关预防静脉血栓用药的36篇文章。
13. Prevention and treatment for deep venous thrombosis and pulmonary thromboembolism in postoperative gynecologic cancer patients
    妇科肿瘤术后深静脉血栓和肺栓塞的防治
14. Here is another hemorrhagic pulmonary infarction in a patient with a pulmonary thromboembolism to a medium sized pulmonary artery.
    这也是一个由于肺中等动脉分支的血栓栓塞所引起的肺出血性梗死。
15. Multiple factors have been implicated in patients with thromboembolism in nephritic syndrome.
    多种因素都与此状况下的血栓栓塞有关。
16. Diagnostic value of arterial blood gas analysis in acute pulmonary thromboembolism
    血气分析对急性肺血栓栓塞症诊断的价值
17. Whether decreasing homocysteine levels with vitamin therapy reduces the risk for venous thromboembolism is not known.
    维生素治疗降低高半胱氨酸水平是否可以降低静脉血栓栓塞形成的风险尚不明确；
18. BACKGROUND& AIMS: Patients with inflammatory bowel disease ( IBD) are at increased risk of a first venous thromboembolism ( VTE), yet their risk of recurrent VTE is unknown.
    背景与目的：炎症性肠病（IBD）患者存在首发静脉血栓栓塞（VTE）的风险增加，然而，目前尚不清楚复发性静脉血栓栓塞的风险。
19. Risk factor of venous thrombosis and pulmonary thromboembolism were inquired.
    调查静脉血栓形成和肺栓塞相关危险因素。
20. ABSTRACT: Venous thromboembolism is a common vascular disease with clinically high morbidity and mortality.
    摘要：静脉血栓栓塞症是临床上引起并发症和死亡的一个重要原因。
21. The tumor is often mistaken for a pulmonary thromboembolism at presentation, and the surgical treatment is usually delayed.
    此肿瘤的表现多被误以为是肺部血栓，因此手术治疗常是延迟的。
22. It can be life-threatening when associated with thromboembolism.
    在与血栓栓塞结合时，深静脉血栓形成可威胁生命。
23. Background: Elevated total homocysteine levels are associated with a higher risk for venous thromboembolism.
    背景――升高的总高半胱氨酸水平与较高的静脉血栓栓塞形成风险相关。
24. The primary outcome was the6-month incidence of recurrent symptomatic, objectively confirmed venous thromboembolism and related deaths.
    主要判断指标是6个月内症状复发的发生率，客观确认的静脉血栓形成以及由此导致的死亡。
25. Whether choosing anticoagulant therapy or not, patients with PAF faced the risk between severe hemorrhage and thromboembolism.
    阵发性房颤是否抗凝治疗使患者面临着严重出血或血栓栓塞风险。
26. Polymorphisms of tissue factor pathway inhibitors C-399T and T-287C in venous thromboembolism
    静脉血栓栓塞症组织因子途径抑制物C-399T和T-287C多态性的研究
27. Dabigatran is at least as efficacious as warfarin in preventing stroke and systemic embolism for patients in whom the risk of thromboembolism outweighs bleeding risk.
    对于血栓栓塞的风险要超过出血风险的病人来说，在预防卒中和全身性栓塞方面达比加群至少和华法林是一样有效的。
28. To compare the thromboembolism effect of Warfarin with Aspirin in preventing non-valvular atrial fibrillation ( AF) patients.
    目的比较华法林与阿司匹林预防非瓣膜性心房颤动（房颤）患者血栓栓塞的疗效。
29. Objective: To determine whether decreasing homocysteine levels alters the risk for symptomatic venous thromboembolism.
    目的――确定降低高半胱氨酸水平是否影响有症状的静脉血栓栓塞形成的风险；
30. Doctor ′ s Knowledge and Mode of Thinking and Diagnosis of Pulmonary Thromboembolism
    医师知识结构和思维方式与肺血栓栓塞症诊断

noun

1. occlusion of a blood vessel by an embolus that has broken away from a thrombus